What Are Capricor Therapeutics Inc.'s Key Financial Figures?
| Fiscal year | FY2025 ended December 31, 2025 | FY2024 ended December 31, 2024 | FY2023 ended December 31, 2023 | FY2022 ended December 31, 2022 |
|---|---|---|---|---|
| Revenue | $0 | $22 million | $25 million | $3 million |
| Operating income | -$108 million | -$43 million | -$24 million | -$30 million |
| Operating margin | n/a | -191.1% | -95.6% | -1163.9% |
| Net income | -$105 million | -$40 million | -$22 million | -$29 million |
| Net margin | n/a | -181.7% | -88.5% | -1137.4% |
| Operating cash flow | -$70 million | -$40 million | -$26 million | $5 million |
| Capital expenditures | $3 million | $1 million | $1 million | $2 million |
| Free cash flow | -$73 million | -$41 million | -$27 million | $3 million |
Free cash flow (operating cash flow minus capital expenditures) was -$73 million against net income of -$105 million; cash generation covered reported earnings.
What Does Capricor Therapeutics Inc.'s Balance Sheet Show?
| Cash and cash equivalents | $288 million |
|---|---|
| Long-term debt | Not reported |
| Total assets | $356 million |
| Total liabilities | $50 million |
| Shareholders' equity | $306 million |
| Current ratio | 9.0x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Capricor Therapeutics Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001104659-26-029580 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Capricor Therapeutics Inc.'s revenue in fiscal 2025?
Capricor Therapeutics Inc. reported revenue of $0 for the fiscal year ended December 31, 2025, according to its SEC filings.
What is Capricor Therapeutics Inc.'s operating margin?
Capricor Therapeutics Inc. did not report operating income under the standard tag for fiscal 2025, so Swoopr does not compute an operating margin; the income statement in its 10-K shows how it presents profit.
How much free cash flow did Capricor Therapeutics Inc. generate?
Operating cash flow of -$70 million less capital expenditures of $3 million gives free cash flow of -$73 million for fiscal 2025.